3rd Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
S. 27 Preserve Access to Affordable Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs |
Medicare/Medicaid MMM
S. 1356 Affordable Medicines Utilization Act of 2011; Medicaid drug rebates in the context of joint select committee negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs |
Health Issues HCR
implementation of PPACA; generic drug user fee (no bill number); S. 296 Preserving Access to Life-Saving Medications Act of 2011;
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs |
Copyright/Patent/Trademark CPT
S. 23 America Invests Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.